Funds will accelerate the commercialisation of innovative UTI diagnostic tests. Llusern’s rapid test offers 35-minute results ...

The test improved prediction of patient benefit from anti-PD-1 immune checkpoint inhibitors (ICIs) as a monotherapy and with ...

The region’s robust healthcare system and ongoing investments in paediatric care are expected ... The market’s upward ...

New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.

The molecular sensing technology can quickly analyze genes and pathogens, cutting diagnosis times to a matter of hours.

COVID-19 presents a broad range of symptoms, varying in intensity from mild to severe and even life-threatening.

SEQ is the first and only assay to receive Medicare coverage for MRD assessment in MCLCoverage leverages new Medicare episode pricing ...

A wide variety of COVID-19 symptoms exist, ranging from mild to severe, and while current strains of the virus generally cause milder symptoms, those with co-morbidities are still at an exponentially ...

New research from Emory University is providing a more precise prediction of COVID-19 severity that can be found by looking ...

Medically reviewed by Soma Mandal, MD A vitamin D test is a blood test that measures the level of vitamin D (calciferol) in ...

New research from Emory University reveals that nasal autoantibodies in COVID-19 patients may help predict disease severity, ...